**Question:** False statement about alagille syndrome

A. Alagille syndrome is a genetic disorder caused by mutations in the NOTCH3 gene.
B. Alagille syndrome is characterized by only liver abnormalities without affecting the cardiovascular system.
C. Alagille syndrome is a rare condition with a prevalence of around 1 in 100,000 live births.
D. Alagille syndrome has no association with the bile ducts or cholestasis.

**Correct Answer:** D. Alagille syndrome has no association with the bile ducts or cholestasis.

**Core Concept:** Alagille syndrome is a rare, multisystem disorder characterized by cholestasis, posterior embryotoxon, and distinct facial features. It is primarily caused by mutations in the NOTCH3 gene, which leads to abnormal development of the cardiovascular, renal, and skeletal systems.

**Why the Correct Answer is Right:** Alagille syndrome is often associated with cholestasis, which is characterized by impaired bile flow and elevated serum bilirubin levels. The NOTCH3 gene mutations lead to abnormal NOTCH signaling, causing impaired differentiation of cells in several organ systems. However, option D is correct as the syndrome does not specifically affect the bile ducts or lead to cholestasis through direct involvement of the bile ducts or cholangiocytes.

**Why Each Wrong Option is Incorrect:**

A. This option is incorrect because mutations in the NOTCH3 gene lead to abnormal NOTCH signaling, affecting multiple organ systems but not specifically the liver or cholestasis.
B. This option is incorrect because Alagille syndrome is characterized by cholestasis and liver involvement. The syndrome directly affects the liver and its function.
C. This option is incorrect because Alagille syndrome has a prevalence of approximately 1 in 1,000,000 live births, making it a rare condition, not affecting the bile ducts or cholestasis.

**Clinical Pearl:** Alagille syndrome is a genetic disorder affecting multiple organ systems, primarily caused by NOTCH3 gene mutations. The syndrome is characterized by cholestasis, posterior embryotoxon, and distinctive facial features. Although it may present with liver involvement, it predominantly affects the cardiovascular, renal, and skeletal systems. Direct involvement of the bile ducts or cholangiocytes is not typically a feature of this syndrome.